Resultados da pesquisa - Muhammad Abdul‐Ghani

Refinar resultados
  1. 1
    Contributions of -Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose

    Contributions of -Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose Por Muhammad Abdul-Ghani

    Publicado em 2006
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes?

    Where Does Combination Therapy With an SGLT2 Inhibitor Plus a DPP-4 Inhibitor Fit in the Management of Type 2 Diabetes? Por Muhammad Abdul-Ghani

    Publicado em 2015
    Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  3. 3
    Pathogenesis of Insulin Resistance in Skeletal Muscle

    Pathogenesis of Insulin Resistance in Skeletal Muscle Por Muhammad Abdul‐Ghani, Ralph A. DeFronzo

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  4. 4
    Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes

    Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes Por Muhammad Abdul‐Ghani, Ralph A. DeFronzo

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention

    Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention Por Ralph A. DeFronzo, Muhammad Abdul‐Ghani

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  6. 6
    Preservation of β-Cell Function: The Key to Diabetes Prevention

    Preservation of β-Cell Function: The Key to Diabetes Prevention Por Ralph A. DeFronzo, Muhammad Abdul‐Ghani

    Publicado em 2011
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  7. 7
    Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm

    Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm Por Muhammad Abdul-Ghani, Ralph A. DeFronzo

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Insulin Resistance and Hyperinsulinemia: the Egg and the Chicken

    Insulin Resistance and Hyperinsulinemia: the Egg and the Chicken Por Muhammad Abdul‐Ghani, Ralph A. DeFronzo

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  9. 9
    Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes

    Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes Por Ralph A. DeFronzo, Roy Eldor, Muhammad Abdul‐Ghani

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    In Vivo Actions of Peroxisome Proliferator–Activated Receptors

    In Vivo Actions of Peroxisome Proliferator–Activated Receptors Por Roy Eldor, Ralph A. DeFronzo, Muhammad Abdul‐Ghani

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  11. 11
    Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30–50% of Filtered Glucose Load in Humans

    Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30–50% of Filtered Glucose Load in Humans Por Muhammad Abdul‐Ghani, Ralph A. DeFronzo, Luke Norton

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

    Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes Por Muhammad Abdul‐Ghani, Luke Norton, Ralph A. DeFronzo

    Publicado em 2011
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  13. 13
    Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus

    Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus Por Muhammad Abdul‐Ghani, Luke Norton, Ralph A. DeFronzo

    Publicado em 2015
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  14. 14
    Treatment of prediabetes

    Treatment of prediabetes Por Mustafa Kanat, Ralph A. DeFronzo, Muhammad Abdul‐Ghani

    Publicado em 2015
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  15. 15
    Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance

    Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance Por Amalia Gastaldelli, Muhammad Abdul‐Ghani, Ralph A. DeFronzo

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Contributions of β-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose

    Contributions of β-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose Por Muhammad Abdul-Ghani, Devjit Tripathy, Ralph A. DeFronzo

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test

    Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test Por Muhammad Abdul-Ghani, Masafumi Matsuda, Bogdan Balas, Ralph A. DeFronzo

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Novel Agents for the Treatment of Type 2 Diabetes

    Novel Agents for the Treatment of Type 2 Diabetes Por Ralph A. DeFronzo, Curtis Triplitt, Muhammad Abdul-Ghani, Eugênio Cersósimo

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Predicting Diabetes in Healthy Population through Machine Learning

    Predicting Diabetes in Healthy Population through Machine Learning Por Hasan Abbas, Lejla Alić, Marelyn Rios, Muhammad Abdul‐Ghani, Khalid Qaraqe

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes

    One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes Por Muhammad Abdul-Ghani, Tamam Abdul‐Ghani, Nibal Ali, Ralph A. DeFronzo

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: